Brimonidine
- Generic Name
- Brimonidine
- Brand Names
- Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza
- Drug Type
- Small Molecule
- Chemical Formula
- C11H10BrN5
- CAS Number
- 59803-98-4
- Unique Ingredient Identifier
- E6GNX3HHTE
- Background
Brimonidine is an alpha-adrenergic agonist and 2-imidazoline derivative that was first introduced in 1996. It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors. Brimonidine displays a higher selectivity toward the alpha-2 adrenergic receptors tha...
- Indication
Opthalmic
Indicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension as monotherapy or combination product with brinzolamide.
Topical
Indicated for the treatment of persistent (non-transient) facial erythema of rosacea in adults 18 years of age or older.
- Associated Conditions
- Increased Intra Ocular Pressure (IOP), Ocular Hypertension, Facial erythema
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.